BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21576762)

  • 1. Class III β-tubulin counteracts the ability of paclitaxel to inhibit cell migration.
    Ganguly A; Yang H; Cabral F
    Oncotarget; 2011 May; 2(5):368-77. PubMed ID: 21576762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Megakaryocyte lineage-specific class VI β-tubulin suppresses microtubule dynamics, fragments microtubules, and blocks cell division.
    Yang H; Ganguly A; Yin S; Cabral F
    Cytoskeleton (Hoboken); 2011 Mar; 68(3):175-87. PubMed ID: 21309084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of mitotic centromere-associated Kinesin stimulates microtubule detachment and confers resistance to paclitaxel.
    Ganguly A; Yang H; Cabral F
    Mol Cancer Ther; 2011 Jun; 10(6):929-37. PubMed ID: 21471284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid substitutions at proline 220 of beta-tubulin confer resistance to paclitaxel and colcemid.
    Yin S; Cabral F; Veeraraghavan S
    Mol Cancer Ther; 2007 Oct; 6(10):2798-806. PubMed ID: 17938271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for class V beta-tubulin effects on microtubule assembly and paclitaxel resistance.
    Bhattacharya R; Cabral F
    J Biol Chem; 2009 May; 284(19):13023-32. PubMed ID: 19282281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of microtubules and their dynamics in cell migration.
    Ganguly A; Yang H; Sharma R; Patel KD; Cabral F
    J Biol Chem; 2012 Dec; 287(52):43359-69. PubMed ID: 23135278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heightened sensitivity to paclitaxel in Class IVa beta-tubulin-transfected cells is lost as expression increases.
    Yang H; Cabral F
    J Biol Chem; 2007 Sep; 282(37):27058-27066. PubMed ID: 17627938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cell migration and cell division correlates with distinct effects of microtubule inhibiting drugs.
    Yang H; Ganguly A; Cabral F
    J Biol Chem; 2010 Oct; 285(42):32242-50. PubMed ID: 20696757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary flavonoid fisetin binds to β-tubulin and disrupts microtubule dynamics in prostate cancer cells.
    Mukhtar E; Adhami VM; Sechi M; Mukhtar H
    Cancer Lett; 2015 Oct; 367(2):173-83. PubMed ID: 26235140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of class III beta-tubulin reduces microtubule assembly and confers resistance to paclitaxel.
    Hari M; Yang H; Zeng C; Canizales M; Cabral F
    Cell Motil Cytoskeleton; 2003 Sep; 56(1):45-56. PubMed ID: 12905530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel-dependent cell lines reveal a novel drug activity.
    Ganguly A; Yang H; Cabral F
    Mol Cancer Ther; 2010 Nov; 9(11):2914-23. PubMed ID: 20978163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Septin filament coalignment with microtubules depends on SEPT9_i1 and tubulin polyglutamylation, and is an early feature of acquired cell resistance to paclitaxel.
    Targa B; Klipfel L; Cantaloube I; Salameh J; Benoit B; Poüs C; Baillet A
    Cell Death Dis; 2019 Jan; 10(2):54. PubMed ID: 30670682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel resistance in cells with reduced beta-tubulin.
    Wang Y; Cabral F
    Biochim Biophys Acta; 2005 Jun; 1744(2):245-55. PubMed ID: 15950754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone.
    Roque DM; Bellone S; Buza N; Romani C; Cocco E; Bignotti E; Ravaggi A; Rutherford TJ; Schwartz PE; Pecorelli S; Santin AD
    Am J Obstet Gynecol; 2013 Jul; 209(1):62.e1-9. PubMed ID: 23583215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human mutations that confer paclitaxel resistance.
    Yin S; Bhattacharya R; Cabral F
    Mol Cancer Ther; 2010 Feb; 9(2):327-35. PubMed ID: 20103599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BetaIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability.
    Kamath K; Wilson L; Cabral F; Jordan MA
    J Biol Chem; 2005 Apr; 280(13):12902-7. PubMed ID: 15695826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular studies reveal mechanistic differences between taccalonolide A and paclitaxel.
    Risinger AL; Mooberry SL
    Cell Cycle; 2011 Jul; 10(13):2162-71. PubMed ID: 21597323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations at leucine 215 of beta-tubulin affect paclitaxel sensitivity by two distinct mechanisms.
    Wang Y; Yin S; Blade K; Cooper G; Menick DR; Cabral F
    Biochemistry; 2006 Jan; 45(1):185-94. PubMed ID: 16388594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics simulation and free energy landscape methods in probing L215H, L217R and L225M βI-tubulin mutations causing paclitaxel resistance in cancer cells.
    Tripathi S; Srivastava G; Sharma A
    Biochem Biophys Res Commun; 2016 Aug; 476(4):273-279. PubMed ID: 27233604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Griseofulvin stabilizes microtubule dynamics, activates p53 and inhibits the proliferation of MCF-7 cells synergistically with vinblastine.
    Rathinasamy K; Jindal B; Asthana J; Singh P; Balaji PV; Panda D
    BMC Cancer; 2010 May; 10():213. PubMed ID: 20482847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.